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1. Introduction 
Respiratory syncytial virus (RSV) is a common winter time respiratory virus that affects 
persons of all ages. RSV was first isolated in children with pulmonary disease in 1957. 
Initially referred to as the ‘chimp coryza virus’, the nature of the virus to form syncytia 
(fusion of cells to form larger cells without any internal cell boundaries) in tissue culture 
subsequently resulted in the virus being named the respiratory syncytial virus. Formation of 
syncytia permits the virus to spread by evading host antibodies (Weir & Fisman , 2004) 
Human RSV is a negative sense enveloped RNA virus and is a member of the family 
Paramyxoviridae, classified within the genus Pneumovirus. RSV has two subtypes A and B 
that are distinguished largely by differences in the viral attachment (G) protein or the 
nuclear (N) protein (Sato et al., 2005). During epidemics, either subtype may predominate, 
or both subtypes may circulate concurrently. RSV is unstable in the environment, readily 
inactivated by soap and water. The virus is spread through close contact with infected 
carriers or contaminated surfaces. Infection occurs when infected materials come in contact 
with the mucous membranes of the eyes, nose or mouth. It is possible that inhaled fomites 
are a source of infection. It can remain infectious on surfaces or fomites for 4-7 hours and 
can also survive on unwashed hands.  
RSV is the main cause of bronchiolitis worldwide and can cause up to 70 or 80 percent of 
lower respiratory infections (LRIs) during high season. The lower respiratory tract includes 
continuation of the airways from the trachea and bronchi to the bronchioles and the alveoli 
(Henrickson, 2004). The common LRIs in children are pneumonia and bronchiolitis and the 
most common causes of viral LRIs are RSVs (Steweart et al., 2009). They tend to be highly 
seasonal, unlike parainfluenza viruses, the next most common cause of viral LRIs.  
Environmental conditions such as temperature, relative humidity and UV-B radiation have 
been described in relation to RSV epidemics (Welliver, 2009). A study performed in Spain 
(Lapena et al., 2005) indicated that low temperature and low absolute humidity were 
positively associated with the number of RSV cases and low absolute humidity was 
independently related to RSV infection. Worldwide, RSV peaks at two temperature 
intervals: between 2-6°C in temperate regions and 24-30°C in tropical regions. RSV activity 
is greatest at 45-65% relative humidity and UV-B radiance inversely related to the number of 
RSV cases. The relation between RSV activity and low minimum temperature indicates that 
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this factor enhances virus transmission. It has been described in earlier studies that 
transmission of RSV is inversely related to temperature in cooler climates and this may be a 
result of increased stability of the virus in the secretions during the colder climate. 
Inactivation of RSV in air has been described (Rechsteiner & Winkler, 1969); stable aerosols 
of RSV were prepared and kept at different relative humidity. Virus recoveries were highest 
at high relative humidity and the stability of the aerosol was maximal at 60% relative 
humidity. This indicates that humidity indeed plays an important role and may affect 
transmission of the virus. 
1.1 Children 
RSV is the largest single cause of childhood hospitalization due to lower respiratory tract 
disease. Infections manifest themselves as mild upper respiratory tract infections or lower 
respiratory tract infections: bronchitis, bronchiolitis, and pneumonia. 10% of those infected 
require specialised paediatric care. High risk groups for severe RSV infection include 
premature infants, children with congenital heart disease, cystic fibrosis and other chronic 
lung disease (Stensballe, 2002). This may be due to the fact that immunity has not become 
fully established, narrow airways, incomplete development of the lungs and relatively short 
bronchial tree. It also affects the elderly and immuno-compromised patients. It has been 
estimated that RSV causes about 500,000 deaths in children each year globally (Shay et al., 
1999). Although, mortality due to RSV is very low in Western Europe, the number of child 
deaths due to acute respiratory infections worldwide is considerable with 70% of deaths 
occurring in Africa and Southeast Asia (Nair et al., 2011). 
 
 Cause of worldwide epidemics, which can occur annually or biennially 
 Most children are infected by 3 years of age 
 Responsible for about 70% of cases of bronchiolitis in children 
 Re-infections occur throughout life and the same serotype can re-infect children and 
adults 
 Associated with recurrent wheeze for many years after bronchiolitis 
 Low birth weight is associated with acute respiratory infections in developing 
countries 
 Cord blood vitamin D deficiency has been associated with Respiratory Syncytial 
Virus Bronchiolitis 
Table 1. Characteristics of RSV infection 
1.2 Adults 
The elderly show increased susceptibility to respiratory infections and other related 
complications. In community dwelling, the elderly suffer fom 1.2 to 1.6 acute respiratory 
infections per year accounting for 25 – 50% of respiratory illness (Nicholson et al., 1997). 
RSV is a significant and unrecognized cause of seasonal respiratory tract infections (RTIs) in 
adults, accounting for as much as 25% of excess wintertime mortality usually attributed to 
influenza. Nearly 80% of RSV associated underlying respiratory and circulatory deaths 
occur among the elderly (Ramirez, 2008). RSV is estimated to account for about 180,000 
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hospital admissions each year exceeding. RSV is also recognized as an important cause of 
viral pneumonia in adults. Clustering of RSV infected patients on wards has suggested 
nosocomial spread by health care workers. Preventive measures such as handwashing are 
important, especially in hospitals and nursing homes where there may be many 
immunocompromised patients. During RSV season, it is advisable to minimize contact 
between high-risk patients and children. 
2. Epidemiology of RSV Infections 
RSV is highly contagious, it is thought that of half the infants that acquire RSV infection 
during the first year of life, approximately 40% of these infections result in lower 
respiratory infections. Virtually all children will have been infected by RSV by the first 3 
years of life. RSV is associated with more deaths than influenza in children aged 1-12 
months. Excess deaths due to RSV and influenza virus infection have also been reported 
for the elderly population.  
2.1 Developed countries 
Epidemics of the virus occur annually and tend to start in November or December and last 4 
to 5 months. In any one year, about 90,000 children will be hospitalized due to RSV and 
4,500 will die. RSV epidemic patterns differ by geographic locations. In the Northern 
hemisphere and particularly, within the United States, RSV mostly circulates between 
November and March (Dawson-Caswell and Muncie 2011). However, the severity of the 
season, peak of activity and time of onset can vary. Communities in the Southern United 
States experience the earliest onset of RSV activity. Midwestern States experience the latest. 
The national average duration is about 15 weeks and can range from 13 to 20 weeks 
(MMWR, 2010). The epidemic pattern of RSV is quite different in regions of Europe (biennial 
epidemics in alternating cycles of approximately 9 and 15 months) than in the Western 
hemisphere (annual epidemics). In Australia, about 100,000 infants are infected by RSV 
every winter. In temperate regions of Australia, the occurrence of annual winter epidemics 
has been well demonstrated (Mullins et al., 2003). The incidence peaks in July, with 55-77% 
of all cases occurring between July and September. Most of the cases of RSV infections in 
Australia occur in children under the age of 4 years. Mechanisms underlying the 
pathogenesis induced by RSV are mostly unknown. RSV induced bronchiolitis in infancy 
may predispose to asthma later in life (Ghildyal et al., 2003). In Germany, Finland, 
Switzerland, Sweden and Croatia, there is a two year RSV cycle repeating every 23 to 25 
months. Unlike Europe, Great Britain experiences a monophasic, annual RSV epidemic 
cycle. In some parts of the USA, RSV cycles are also monophasic and annual (Milinaric-
Galinovic et al., 2008)..  
2.2 Developing countries 
In developing countries, respiratory diseases represent a challenge to public health because 
of their severity, frequency, trends, and economic impact. Data from developing countries 
are even more limited in the ability to provide a clear estimate of disease burden. Published 
in 1998, a review of the literature on RSV in tropical and developing countries identified from 
ten longitudinal community-based studies that RSV was the etiological agent in 2% (in India) 
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to 73% (in Brazil) of lower respiratory infection episodes (Weber et al. 1998). Three studies 
(from Brazil, Uruguay, and Colombia) reported RSV as being the etiological agent in more 
than 50% of the community-based acute lower respiratory tract infection episodes. The authors 
identified the limitations associated with different methods used by the different studies to 
detect RSV. In general, studies that used immunofluorescence methods had higher rates of 
RSV detection, and the majority of the community-based longitudinal studies that had low 
RSV detection rates used culture alone. The same review examined the more abundant 
hospital-based studies in tropical and developing countries and found that RSV was detected 
in between 6 and 96% of cases of hospitalised lower respiratory tract infections. On average, 
RSV accounted for 65% of samples that were positive for a virus (range 27-96%); and 17% of 
acute respiratory tract infections in children admitted to hospital. 
There is relatively scant information for the role of RSV in causing LRI among children in 
developing countries. Hence the WHO introduced standardized protocols for new studies to 
be undertaken in these regions. This was first performed in, Mozambique, Indonesia, 
Nigeria and South Africa (Robertson et al., 2004). The total incidence of LRIs occurring 
among children aged < 1 year was lowest in Indonesia and highest in Mozambique where 
50% of children presented with an LRI and 13% were hospitalized. Among infants, RSV 
infections identified were 36% in Nigeria, 23% in Indonesia and 6% in Mozambique. For 
severe RSV attributable LRIs, the proportion was high in Indonesia but low in Mozambique. 
The rates of severe illness in children < 1 year in Indonesia, Mozambique and South Africa 
(15-16/1000 child years) are very similar to rates of hospitalization from industrialized 
countries eg. England (20/1000 child years), Germany (12/1000 child years), Norway 
(10/1000 child years), USA (20/1000 child years) and Austria (6/1000 child years). 
Differences in RSV rates in developing countries also depends on many social factors such 
fewer health centres, large families with many children facilitates more spread of infections. 
In some countries such as South Africa and Mozambique, the peak for RSV correlates with 
the presence or absence of rainfall. 
2.3 RSV Infections in the Middle East 
Little is known about the epidemiology of RSV infections in the Middle East and other 
desert climate regions of the world. The Middle East has large areas covered by desert. In 
summer, it is hot and can be very humid, whereas in winter, temperature can drop 
significantly. These weather variations can exacerbate respiratory infections (ARI) and 
chronic lung diseases in susceptible individuals especially asthmatics (Waness et al., 2011). 
Acute respiratory infections play a major role in hospitalizations in the Middle East. The 
number of children admitted with RSV diseases from developing countries in 2005 was 
more than double that estimated in 1986, and the incidence of RSV-acute lower respiratory 
tract (ALRI) was twice that of industrialized countries (Nair et al., 2010) 
A review of RSV infections in the Middle East region (Table 2) shows that the occurrence of 
RSV infections is in the Winter season peaking around January as in other parts of the 
world, with the same age groups affected. This is in contrast to some developing countries 
eg. Indonesia, where the incidence of RSV LRI in the first 6 months of life is relatively low. 
Most cases of disease occur in older children (Simoes et al., 2011). A more precise 
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understanding of the timing of annual RSV epidemics should assist providers in 
maximizing the benefit of preventive therapies.  
The current data on the load and importance of viral respiratory infection and 
hospitalization is scarce. Recipients of bone marrow transplant have been reported to 
have mortality rates over 50% with RSV pneumonia. Molecular epidemiologic studies 
have demonstrated that RSV nosocomial outbreaks often result from multiple 
introductions of distinct strains from the community. In Saudi Arabia a review of RSV 
hospitalizations showed that the majority of cases are due to bronchopneumonia, 
prematurity and lung, heart disorders (Al-Muhsen, 2010). In Jordan, RSV positive 
children require higher rates of oxygen use and longer hospital stay, which is a financial 
burden for poor countries (Khuri-Bulos et al., 2010). A study in Kuwait (Hijazi et al., 1997) 
found that RSV was the commonest agent identified in 52% cases of bronchiolitis, 29% of 
pneumonia and 51% of croup. Another study in Al Ain has shown that the clinical pattern 
of RSV infections includes bronchiolitis in 58% of cases, bronchopneumonia in 19% of 
cases and pneumonia 11%. RSV was strongly associated with cool temperatures and 
relative humidity between 50-60% (Uduman et al., 1996). The cycle of RSV infections is 
also less defined in the Middle East. In Saudi Arabia, the pattern appears to show regular 
rates of infection with a slower peak approximately at 3 years (Fig 1). Such trends need to 
be monitored and extended to other Middle Eastern countries. 
Children younger than 60 days and those with severe symptoms may require 
hospitalization. Neither antibiotics nor corticosteroids are helpful for bronchiolitis. A 
bronchodilator trial is appropriate for children with wheezing, but should not be 
continued unless there is a prompt favorable response (Jafri, 2003). Frequent hand 
washing and contact isolation may prevent the spread of RSV infections. Children 
younger than two years at high risk of severe illness, including those born before 35 
weeks of gestation and those with chronic lung or cardiac problems, may be candidates 
for palivizumab prophylaxis for RSV infection during the peak infection season 
(Lieberthal et al., 2006).  
Recent studies have shown that Vitamin D deficiency in healthy neonates is associated with 
increased risk of RSV LRTI in the first year of life (Belderbos, et al., 2011). Vitamin D 
supplementation during pregnancy may be a useful strategy to prevent RSV LRTI during 
infancy. This could be particularly significant in Saudi Arabia and other developing 
countries where there is a high level of vitamin D deficiency among the population.  
Hajj pilgrimage is a yearly event in which >2 million Muslims from around the world gather 
in Mecca, Saudi Arabia. Such high density of crowding presents a risk for local outbreaks 
and for worldwide spread of infectious agents. ARI is the leading cause of admission to 
Saudi hospitals during the Hajj (Ahmed et al., 2006). The close contact among pilgrims 
during periods of intense congestion, their shared sleeping accommodations (mainly in 
tents) and the dense air pollution all combine to increase the risk of airborne respiratory 
disease transmission. A viral etiology of upper respiratory tract infection (URTI) is most 
commonly implicated at the Hajj, but bacterial super infection often follows. More than 200 
viruses can cause URTI at the Hajj. The main etiologies are RSV, parainfluenza, influenza 
and adenovirus (Rashid et al, 2008). 
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Country 
Seasonality 
of RSV 
(Start) 
Seasonality 
of RSV 
(End) 
Prevalence of RSV 
in Lower 
Respiratory Tract 
Infection 
Study Size 
(patient 
number) 
Age 
Group 
affected 
Authors 
Saudi 
Arabia 
(Riyadh) 
November February 83% 883 <5 years 
Akhter  
et al., 2008 
Saudi 
Arabia 
(Qassim 
Region) 
December February 45.4% 282 < 1 year 
Meqdam M  
et al 2006 
Saudi 
Arabia 
(Abha 
Region) 
November February 40% 115 < 2 years 
Al Shehri  
et al 2005 
Saudi 
Arabia 
(Riyadh) 
November February 28.5% 256 < 5 years 
Al Hajjar  
et al  
1993-1996 
Kuwait October March 36.8 % 1,014 < 1 year 
Khadada M. 
et al 2010 
Lebanon December May 26.7% 120 < 6 years 
Hamze A  
et al 
 2007-2008 
Jordan December March 12.5% 200 < 2 years 
Al Toum R  
et al 2006 
Turkey January March 29.5% 332 < 2 years 
Kanra  
et al 2005 
UAE November february 28.6% 252 < 3 years 
Uduman SA 
et al  
1993 - 1995 
Qatar November February 59.9% 257 < 1 year 
Wahab 
et al 1996-
1998 
Egypt December February 16.4% 91 < 5 years 
Fattouh  
et al 2011 
Table 2. Seasonality of RSV Infections Observed in the Middle East 
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Number 
of 
Patients 
Predisposing factors 
Age 
Range 
Location Treatment Author 
94 
Premature, 
pulmonary pathology, 
neurological and 
cardio-vascular 
abnormalities 
<1 
year 
Riyadh 
Oxygen 
supplementation, 
bronchodilators, 
antibiotics 
Al 
Muhsen, 
2010 
8 
Pre term, 
ARDS 
28 
weeks 
Riyadh 
Mechanical 
ventilation, 
support 
Kilani, 
2002 
412 
Bronchopneumonia. 
broncihiolitis 
< 5 
years 
Riyadh  
Bakir 
et al, 1998 
69  
< 1 
year 
Riyadh 
Supportive, 
antibiotics 
Jamjoom 
et al, 1993 
51 
Prematurity, chronic 
lung diseases, atopic 
dermatitis, pure 
formula feeding, 
passive smoking 
< 2 
years 
Abha 
Supportive, 
Oxygen 
Al 
Shehri, 
2005 
128 
bronchopneumonia 
bronchiolits Coughing 
tachpnea 
< 1 
year 
Qassim antibiotics 
Meqdam, 
2006 
Table 3. Characterisitics of RSV Infections in hospitalized Patients in Saudi Arabia 
 
Fig. 1. Prevalence of RSV Infections between 2004 – 2010 at a tertiary Care Center in Saudi 
Arabia (Akhter, et al., 2008) 
www.intechopen.com
 
Human Respiratory Syncytial Virus Infection 
 
168 
3. Laboratory diagnosis 
Early diagnosis of RSV infection enables timely interventions to be introduced to control the 
spread of disease. Given the similarity in clinical presentation to influenza and human 
metapneumovirus, laboratory confirmation provides a definitive diagnosis of RSV infection. 
Clinical features of RSV infections overlap with other respiratory viruses so laboratory 
diagnosis is essential to establish diagnosis. Prior to the introduction of molecular 
diagnostics, respiratory viruses were primarily identified by virus isolation in tissue culture 
or antibody/antigen detection by serological methods: Specimens should be collected in the 
acute stage of the illness, kept moist, and refrigerated immediately.  
3.1 Imaging studies 
Chest radiography is frequently obtained in children with severe RSV infection. Chest 
radiography typically reveals hyperinflated lung fields with a diffuse increase in interstitial 
markings. In 20-25% of cases, focal areas of atelectasis and/or pulmonary infiltrate are also 
noted. Generally, these findings are neither specific to RSV infection nor predictive of the 
course or outcome, except for the observation that infants who have the additional findings 
of atelectasis and/or pneumonia may have a more severe course with their illness. 
3.2 Clinical specimens 
Nasopharyngeal aspirates (NPAs), swabs and washes are acceptable for culture, direct 
antigen detection and Nucleic acid testing (NAT) where this is available. Other acceptable 
specimens are endotracheal aspirates, bronchoalveolar lavage fluid and lung biopsy tissue. 
Swabs should be cotton, rayon or dacron-tipped, plastic-coated or aluminium shafted 
swabs. They should be placed into viral transport media and transported at 4°C or frozen at 
-70°C. Unacceptable specimens include Calcium alginate swabs or swabs in gel media, 
wooden swabs and dry swabs 
3.3 Tissue culture methods 
A cost-effective and relatively rapid approach to detecting RSV in humans is to use cell 
cultures in conjunction with immunofluorescence antibody (IFA) methods. Traditional cell 
cultures, while being sensitive, required long incubation periods. Recent advances have led 
to the development of enhanced cell lines that require shorter incubation periods but are 
also cocultivated (or contain mixed cell lines) to detect several viruses in the same culture 
vial (Lanley et al. 2007). The benefits of such cell line mixes in terms of providing a rapid 
and sensitive method for detecting respiratory viruses including RSV have been established, 
however, RSV detection is optimised by supplementing cell line cultures with the non-
culture method of direct immunofluorescence Assay (DFA) (Leland and Ginocchia. 2007). 
Viral culture is the gold standard by which other tests are compared. Specificity is not 
usually an issue; however, sensitivity in adults can be problematic. Adults generally shed 
lower titres and for a shorter period of time than children. Also, the virus is thermolabile 
and does not survive lengthy transit times. Culture is only 20 – 45% sensitive when 
compared with serology using acute and convalescent sera. The benefits of tissue culture are 
its broad sensitivity for a range of viruses, the necessity for infectious virus particles and its 
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relatively low cost. Human heteroploid cells, such as HEP-2 and HeLa generally provide the 
best tissue culture for RSV isolation. RSV produces a characteristic CPE consisting of 
syncytia formation and appears in 4 to 5 days. 
Mixed cell line cultures were used for the first time at a tertiary care center in Saudi Arabia 
to accelerate virus isolation (Akhter et al). Rapid testing algorithms allowed all respiratory 
syncytial virus (RSV) isolates to be detected in one day, influenza isolates to be detected in 2 
days, parainfluenza isolates within 3 days, and adenovirus in 2-5 days. 92% of RSV 
infections occurred in children one year and under. RSV infections occurred between 
November and February, with a peak in January. Influenza and adenovirus outbreaks 
occurred in November and December. Parainfluenza occurred in 2 waves, first in November 
and December followed by another peak in April. RSV appears to occur in a two year cycle 
similar to Europe (Fig 1) 
3.4 Shell vial assay 
Laboratory diagnosis of RV infections has become easier and more rapid with the use of 
centrifugation-enhanced shell vials (SV) as the culture method. Centrifugation of the clinical 
specimen onto cell monolayers followed by immunofluorescence detection and 
identification of viral antigens in SV cultures allows a much earlier diagnosis of infection. In 
this technique a small bottle (vial) with a removable round glass cover slip is used to grow 
the cells as a monolayer on the cover slip. Nowadays mixed cell types can be put in a single 
monolayer providing a variety of cell types for the virus to infect in a single vial. Once these 
monolayers are ready to be inoculated, the growth medium is removed from the vial and 
the clinical sample placed directly on the monolayer. The vial is then centrifuged, the clinical 
sample is removed and fresh growth medium is then added to the vial. It is possible, using 
this technique, to identify the presence of a virus before CPE occurs by using fluorescent 
monoclonal antibodies to detect early and pre-early proteins. The disadvantage of this 
method is it is not possible to do "blind passages". Some viruses may require longer 
incubation to adapt to the particular cell lines. Once used, the monolayer can not be re-
incubated or re-inoculated as the fixed cells and viruses are not viable (Gleaves et al., 1984). 
3.5 Antigen detection 
Several ELISA kits are available for the detection of RSV antigens on a solid phase. ELISA 
techniques offer the advantages of objective interpretation, speed, and the possibility of 
screening a large number of specimens. Disadvantages include a generally poorer sensitivity 
and a "grey zone" of equivocal results, which requires confirmation by a time-consuming 
blocking ELISA procedure (Casiano et al., 2003). Both direct and indirect IF utilizing either 
polyclonal or monoclonal antibodies are available which possess a high degree of sensitivity 
and specificity. The general sensitivity of IF is 80 - 90% and for monoclonal antibody 95 - 
100% (Aldous et al., 2004). IF techniques are fast and easy to perform but the interpretation 
of results is subjective and the specimen must contain adequate nasopharyngeal cells. 
Detection of RSV antigens in respiratory secretions by IFA or EIA is widely used in children 
and removes the need to recover infectious virus but requires a significant viral load to 
generate a positive result. Hence, these methods are not suitable for adults as studies have 
shown positive rates of only 23% by IFA and 10% by EIA.  
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3.6 Serology 
Serologic diagnosis requires paired serum specimens in most instances and is intrinsically 
slower than direct methods. A variety of serologic techniques are used to measure 
antibodies, including neutralization, hemagglutination inhibition, complement fixation, and 
enzyme-linked immunosorbent assay (ELISA). Measurement of complement-fixation 
antibodies is generally less sensitive than the other methods and does not provide a 
serotype-specific diagnosis. Immunocompromised hosts often fail to develop diagnostic 
increases in antibody titers. RSV infections reoccur throughout life diagnosis can be 
demonstrated by a greater ≥ 4 fold increase in RSV specific IgG. When baseline sera are 
available, this method is ≥ 90% sensitive for diagnosis of RSV infection in the elderly. 
However utility of serology is limited to its retrospective nature (Falsey et al., 2003). 
3.7 Molecular methods 
The principal amplification technique used for RNA viruses is reverse-transcriptase 
polymerase-chain reaction (RT-PCR). Detection of RNA viruses requires an additional first 
step in which RNA is reverse transcribed to complementary DNA before PCR amplification. 
Theoretically, this technique is capable of detecting a single virus within 24 hours. Detection 
of the amplified sequence may be done at the reaction endpoint, or by continuous 
monitoring (real-time PCR). Real-time PCR has the advantage of allowing the virus to be 
quantified (Whiley et al., 2002).  
Multiplex PCR methods have been developed that allow the detection of more than one 
nucleic acid sequence, and therefore more than one virus type, in the same assay. These are 
based on the principle that products of real time cyclers can be detected simultaneously at 
different wavelengths of fluoresence. Other nucleic acid amplification methods have also 
been developed, notably nucleic acid sequence base amplification (NASBA). This technique 
is also known as isothermal amplification, as it does not require the repeated temperature 
cycling used in conventional PCR methods (Beck & Henrickson, 2010).  
The advantages of PCR and related methods are considerable. The main benefit is time 
saving allowing hours to a result rather than several days as for a cell culture assay. PCR 
also requires less operator skill and training to carry out and can be automated to process 
large numbers of samples. It is also extremely sensitive, although it can be vulnerable to 
contamination and cannot distinguish infective viruses. Most PCR methods require some 
costly equipment and are not suitable for use outside the laboratory. Non-quantitative 
PCR results may also be difficult to interpret, since low numbers of virus that do not 
signify an infection may be detected, but this problem is largely overcome by real-time 
PCR. Molecuar methods can also detect several orders of magnitude less than tissue 
culture methods (Borg et al., 2003). 
3.8 Microarrays 
DNA microarrays used as 'genomic sensors' have great potential in clinical diagnostics. 
Microarray analysis has the capability to offer multiplex detection, Multiple microarray 
platforms exist, including printed double-stranded DNA and oligonucleotide arrays, in situ-
synthesized arrays, high-density bead arrays, electronic microarrays, and suspension bead 
arrays (Wong et al., 2007). In general terms, probes are synthesized and immobilized as 
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discrete features, or spots. Each feature contains millions of identical probes. The target is 
fluorescently labeled and then hybridized to the probe microarray. A successful 
hybridization event between the labeled target and the immobilized probe will result in an 
increase of fluorescence intensity over a background level, which can be measured using a 
fluorescent scanner. Biases inherent in random PCR-amplification, cross-hybridization 
effects, and inadequate microarray analysis, however, limit detection sensitivity and 
specificity (Miller & Tang, 2009). 
3.9 Emerging technologies 
There are several emerging molecular assays that have potential applications in the 
diagnosis and monitoring of respiratory viral infections (Takahashi et al., 2008). These 
techniques include direct nucleic acid detection by quantum dots, loop-mediated isothermal 
amplification; multiplex ligation-dependent probe amplification, amplification using 
arbitrary primers, target-enriched multiplexing amplification, pyrosequencing, padlock 
probes, solid and suspension microarrays, and mass spectrometry (Wu & Tang, 2009). 
Several of these systems already are commercially available to provide multiplex 
amplification and high-throughput detection and identification of a panel of respiratory 
viral pathogens. Further validation and implementation of such emerging molecular assays 
in routine clinical virology services will enhance the rapid diagnosis of respiratory viral 
infections and improve patient care. 
 
Method of 
Detection 
Advantage Disadvantage 
Virus 
Culture 
Characteristic syncytial CPE 
allows identification 
Broad sensitivity 
Time-consuming 
Need confirmatory identification 
method 
Requires expertise to maintain cell 
lines 
Antigen 
Detection 
(IFA and 
EIA) 
Commercial kits widely 
available 
Rapid ID 
Suitable for screening large 
numbers 
Can give false results 
Does not allow for genotyping 
PCR 
Rapid addition of new viruses 
Detection of unidentified 
respiratory viruses 
Suitable for early detection and 
monitoring of viruses 
Highly sensitive but sometimes 
false products 
Containment of amplicons to 
prevent contamination 
Real Time 
PCR 
Rapid product confirmation 
High Sensitivity and Specificity 
Automated 
Limited number of virus detection 
in one-tube 
False signal 
High cost 
Microarrays 
Rapid 
Can screen multiple pathogens 
Low sensitivity 
False signal 
Table 4. Methods Used For Laboratory Diagnosis of RSV 
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4. Conclusion 
Lower respiratory tract infections caused by RSV occur epidemically, and the appearance 
of epidemics seems to vary with latitude, altitude and climate. Onset weeks and durations 
of RSV seasons also vary substantially by year and location. Local RSV data are needed to 
accurately define the onset and offset of RSV seasons and to refine timing of passive 
immune prophylaxis therapy recommendations. Further studies on RSV particularly in 
developing countries should address these questions in more detail. RSV is an important 
pathogen of young children in tropical and developing countries and a frequent cause of 
hospital admission. Prevention of RSV disease relies on rapid diagnosis, infection control 
and hygiene measures, as well as providing immunoprophylaxis in select infants. The 
prophylaxis, however, is costly, and so targeting the recipient population and timing of 
administration is important for optimal effectiveness and judicious use of limited health 
care resources 
The relative proportions of different genotypes vary from year to year with steady 
replacement of the dominant genotype each year, suggesting that herd immunity may play 
a role in the abundance of a particular genotype in a particular epidemic. A small study in 
Hungary (Pankovics et al., 2009) using molecular detection and genetic analysis showed that 
based upon the F region 96% viruses genetically belonged to type A and 4% were classified 
as type B human RSV. Based upon the G region, out of the type A viruses 72.7% belonged to 
group GA5 and 27.3% to group GA2. Viral nucleotide sequence was identical in several 
cases. A Japanese study (Shobugawa et al., 2009) investigated a total of 488 human RSV 
samples from 1,103 screened cases in a pediatric clinic in Niigata. According to the 
phylogenetic analysis, among the PCR-positive samples, 338 HRSV-A strains clustered into 
the previously reported genotypes GA5 and GA7 and two novel genotypes, NA1 and NA2, 
which were genetically close to GA2 strains. Another study In India (Agrawal et al., 2009) 
showed that 95% were group B strains and 5% group A. Similarly, an outbreak in Turkey 
indicated that subgroup B was highly dominant (Guney et al., 2004). In Thailand, equal 
infectivity and severity of both RSV subgroups has been shown ( Boonyasuppayakom et al., 
2007). Such knowledge has yet to be ascertained for the Middle Eastern countries. There is a 
dustinct need to carry out molecular typing of RSV in Saudi Arabia and other surrounding 
countries to further elucidate the pattern of infections, the prevalent strains circulating in the 
region and possible approaches for treatment. The importance of RSV infections has 
resulted in surveillance monitoring being conducted in Europe and other developed 
countries. Such coordinated strategies are important to consider in developing countries 
where the impact of RSV infections is greater. 
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